Skip to content

Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy

Down Syndrome | Fetal Aneuploidy

The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.

null

Conditions de participation

  • Sexe:

    FEMALE

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

* pregnant between 10 and 22 weeks gestation
* 18 years of age or older
* provides signed and dated informed consent
* subject is at increased risk for fetal aneuploidy
* subject is willing to undergo a CVS and/or amniocentesis procedure for the purpose of genetic analysis
* subject agrees to provide the genetic results of the invasive procedure

Exclusion Criteria:

* Fetal demise at time of specimen sampling
* Previous sample donation under this protocol

Lieu de l'étude

North York General Hospital
North York General Hospital
Toronto, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Clare Gibbons

[email protected]
416 756-6788
IWK Health Centre
IWK Health Centre
Halifax, Nova Scotia
Canada

Contactez l'équipe d'étude

Backup Contact

Jo-Ann Brock, MD

Étude parrainée par
Sequenom, Inc.
Participants recherchés
Plus d'informations
ID de l'étude: NCT01429389